References
- Cattabeni F., Spano P. F., Costa E. Advances in Biochemical Psychopharmacology. Raven Press, New York 1980; Vol. 24
- Casey D. E., Chase T. N., Christensen A. V., Gerlach J. Psychopharmacology. Springer-Verlach, Berlin, Heidelberg, New York, Tokyo 1985, Suppl. 2
- Leysen J. E. Neuropharmacology of serotonin, A. R. Green. Oxford Medical Publications, Oxford 1985; 79–109
- Idzikowski C., Mills F. J., Glennard R. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Res. 1986; 378: 164–168
- Peroutka S. J., Snyder S. H. Regulation of serotonin2 (5-HT2) receptors labeled with [3H] spiroperidol by chronic treatment with the antidepressant amitriptyline. J. Pharmacol. Exp. Ther. 1980; 215: 582–587
- Hyttel J., Fredericson-OverØ K., Arnt J. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 1984; 83: 20–27
- Hall H., Ross S. B., SÄLlemark M. Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants on β-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex. J. Neural. Transm. 1984; 59: 9–23
- Stockmeier C. A., Kellar K. J. In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci. 1986; 38: 117–127
- Blackshear M. A., Friedman R. L., Sanders-Bush E. Acute and chronic effects of serotonin (5-HT) antagonists on serotonin binding sites. Naunyn-Schmiedebergs Arch. Pharmacol. 1983; 324: 125–129
- Gandolfi O., Barbaccia M. L., Costa E. Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites. Life Sci. 1985; 36: 713–721
- Leysen J. E., Van Gompel P., Gommeren W., Woestenborghs R., Janssen P. A.J. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Psychopharmacology 1986; 88: 434–444
- Niemegeers C. J.E., Leysen J. E., Laduron P. M., Janssen P. A.J. Collegium Internationale Neuro-Psychopharmacologicum. 14th Congress. 1984, 889, Book of Abstract
- Leysen J. E., Gommeren W. Drug-receptor dissociation time, new tool for drug research-receptor-binding affinity and drug-receptor dissociation profiles of serotonin-S2, dopamine-D2, histamine-H-1 antagonists, and opiates. Drug. Dev. Res. 1986; 8: 119–131
- Niemegeers C. J.E., Lenaerts F. M., Artois K. S.K., Janssen P. A.J. Interaction of drugs with apomorphine, tryptamine and norepinephrine. A new “in vivo” approach: the ATN-test in rats. Arch. Int. Pharmacodyn. Ther. 1977; 227: 238–253
- Christensen A. Y., Fjallaud B., MØLler-Nielsen I. On the supersensitivity of dopamine receptors, induced by neuroleptics. Psychopharmacology 1976; 48: 1–6
- De Chaffoy De Courcelles D., Leysen J. E., De Clerck F., Van Belle H., Janssen P. A.J. Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. J. Biol. Chem. 1985; 260: 7603–7608
- De Chaffoy De Courcelles D., Leysen J. E., Roevens P., Van Belle H. The serotonin-S2 receptor: A receptor-transducer coupling model to explain insurmountable antagonist effects. Drug. Dev. Res. 1986; 8: 173–178